$225,220
－2.4%
Ceo/Cso
2024
$218k
40 hrs/wk
$8k
--
Ceo/Cso at Odylia Therapeutics Inc.
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Ashley Winslow has been listed as an employee of Odylia Therapeutics Inc. in Form 990 filings since fiscal year 2019. Total compensation for Ashley Winslow has increased by 414% from 2019 to 2024.